MAILING at-home HPV kits doubles cervical cancer screening uptake in hard-to-reach women, a study shows.
Sending out the tests helps the poorest, most at-risk women, US researchers found — potentially saving lives.
The tests allow women to give themselves a swab, rather than having to go to a doctor for the intimate procedure.
Professor Jennifer Smith, of University of North Carolina at Chapel Hill, said: “Mailed HPV kits can greatly improve screening uptake among underserved, at-risk women.
“We were thrilled to find a nearly two-fold increase in screening uptake.
Urgent warning over 'silent killer' cancer that can first appear as back pain
“Many hadn’t engaged in the screening system for a while and getting the kit to their homes helped break down a fundamental barrier.”
The NHS started a trial of at-home tests in 2021, sending kits out to more than 31,000 women living in low-uptake areas in London.
They were sent to women aged 25 to 64 who were 15 months overdue for a check, with the aim of improving uptake.
Embarrassment, cultural barriers and fear about what it involves are often a key reason for women not attending appointments in-person, the health service said.
The tests identify whether you are positive for HPV — the virus that causes 99.7 per cent of cervical cancers.
Around 3,200 women are diagnosed with cervical cancer each year, with a quarter of them dying.
At-home tests differ from traditional smear tests you get at your GP because they do not take a sample of cells that can be analysed for abnormalities if you are positive for HPV.
This still needs to be done in-person by a medical professional.
The latest study, published in Lancet Public Health, looked at how successful sending at-home tests out were for boosting uptake in a US population.
Some 665 women aged 42 on average that had not had a smear test in at least four years were recruited.
Pele's body arrives at football stadium for fans to say final farewell
One group was sent out the test kits and also given help to book an in-person appointment, while the other was only assisted in booking an appointment.
Some 72 per cent of the first group had a test, compared to 37 per cent in the second group.
Of the 16 per cent who tested positive on the at-home kits, 42 per cent attended a follow-up referral for a full smear test.
Dr Noel Brewer, of the University of North Carolina at Chapel Hill, said: “Government approval of at-home HPV tests would have a huge impact.
“We could better reach those in rural areas where cervical cancer screening is hard to come by.
“Also, only the people who self-test positive would need to go to a clinic for screening.”
